SE504582C2 - Cyklosporinkomposition baserad på en L2-fas - Google Patents

Cyklosporinkomposition baserad på en L2-fas

Info

Publication number
SE504582C2
SE504582C2 SE9502472A SE9502472A SE504582C2 SE 504582 C2 SE504582 C2 SE 504582C2 SE 9502472 A SE9502472 A SE 9502472A SE 9502472 A SE9502472 A SE 9502472A SE 504582 C2 SE504582 C2 SE 504582C2
Authority
SE
Sweden
Prior art keywords
cyclosporin
phase
monoglyceride
composition according
triglyceride
Prior art date
Application number
SE9502472A
Other languages
English (en)
Swedish (sv)
Other versions
SE9502472L (sv
SE9502472D0 (sv
Inventor
Kaare Larsson
Helena Ljusberg-Wahren
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Priority to SE9502472A priority Critical patent/SE504582C2/sv
Publication of SE9502472D0 publication Critical patent/SE9502472D0/xx
Priority to DE0873133T priority patent/DE873133T1/de
Priority to BR9609332A priority patent/BR9609332A/pt
Priority to CA002226219A priority patent/CA2226219A1/en
Priority to ES96923154T priority patent/ES2123477T3/es
Priority to EP96923154A priority patent/EP0873133B1/en
Priority to PCT/SE1996/000893 priority patent/WO1997002042A1/en
Priority to CZ9819A priority patent/CZ1998A3/cs
Priority to AT96923154T priority patent/ATE213951T1/de
Priority to AU63745/96A priority patent/AU6374596A/en
Priority to JP9505078A priority patent/JPH11508592A/ja
Priority to DE69619700T priority patent/DE69619700T2/de
Publication of SE9502472L publication Critical patent/SE9502472L/
Publication of SE504582C2 publication Critical patent/SE504582C2/sv
Priority to NO980032A priority patent/NO980032L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9502472A 1995-07-06 1995-07-06 Cyklosporinkomposition baserad på en L2-fas SE504582C2 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE9502472A SE504582C2 (sv) 1995-07-06 1995-07-06 Cyklosporinkomposition baserad på en L2-fas
DE69619700T DE69619700T2 (de) 1995-07-06 1996-07-02 Cyclosporin enthaltende, biologisch aktive zubereitung
PCT/SE1996/000893 WO1997002042A1 (en) 1995-07-06 1996-07-02 Biologically active composition comprising cyclosporine
AT96923154T ATE213951T1 (de) 1995-07-06 1996-07-02 Cyclosporin enthaltende, biologisch aktive zubereitung
CA002226219A CA2226219A1 (en) 1995-07-06 1996-07-02 Biologically active composition comprising cyclosporine
ES96923154T ES2123477T3 (es) 1995-07-06 1996-07-02 Composicion biologicamente activa que comprende ciclosporina.
EP96923154A EP0873133B1 (en) 1995-07-06 1996-07-02 Biologically active composition comprising cyclosporine
DE0873133T DE873133T1 (de) 1995-07-06 1996-07-02 Cyclosporine enthaltende, biologisch aktive zubereitung
CZ9819A CZ1998A3 (cs) 1995-07-06 1996-07-02 Biologicky aktivní přípravek obsahující cyklosporin
BR9609332A BR9609332A (pt) 1995-07-06 1996-07-02 Composição biologicamente ativa processo para a fabricação da mesma e uso de uma fase
AU63745/96A AU6374596A (en) 1995-07-06 1996-07-02 Biologically active composition comprising cyclosporine
JP9505078A JPH11508592A (ja) 1995-07-06 1996-07-02 シクロスポリンからなる生物活性組成物
NO980032A NO980032L (no) 1995-07-06 1998-01-05 Biologisk aktiv blanding omfattende cyklosporin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9502472A SE504582C2 (sv) 1995-07-06 1995-07-06 Cyklosporinkomposition baserad på en L2-fas

Publications (3)

Publication Number Publication Date
SE9502472D0 SE9502472D0 (sv) 1995-07-06
SE9502472L SE9502472L (sv) 1997-01-07
SE504582C2 true SE504582C2 (sv) 1997-03-10

Family

ID=20398887

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9502472A SE504582C2 (sv) 1995-07-06 1995-07-06 Cyklosporinkomposition baserad på en L2-fas

Country Status (12)

Country Link
EP (1) EP0873133B1 (es)
JP (1) JPH11508592A (es)
AT (1) ATE213951T1 (es)
AU (1) AU6374596A (es)
BR (1) BR9609332A (es)
CA (1) CA2226219A1 (es)
CZ (1) CZ1998A3 (es)
DE (2) DE873133T1 (es)
ES (1) ES2123477T3 (es)
NO (1) NO980032L (es)
SE (1) SE504582C2 (es)
WO (1) WO1997002042A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE511313C2 (sv) 1997-01-13 1999-09-06 Gs Dev Ab Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
CA2313024C (en) 1997-12-10 2008-06-03 Severson, Mary L. Pharmaceutical compositions containing an omega-3 fatty acid oil
BR9916063A (pt) * 1998-12-11 2002-01-22 Pharmasolutions Inc Composições auto-emulsificantes para medicamentos fracamente solúveis em água
CA2466432A1 (en) 2001-11-08 2003-05-15 Atrium Medical Corporation Intraluminal device with a coating containing a therapeutic agent
WO2007011385A2 (en) 2004-09-28 2007-01-25 Atrium Medical Corporation Heat cured gel and method of making
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036967A1 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Solubilizing a drug for use in a coating
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
WO2007047781A2 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
EP2083875B1 (en) 2006-11-06 2013-03-27 Atrium Medical Corporation Coated surgical mesh
ES2400964T3 (es) 2007-04-04 2013-04-15 Sigmoid Pharma Limited Composiciones famacéuticas de ciclosporina
CN102470106B (zh) 2009-05-18 2015-09-23 希格默伊德药业有限公司 包含油滴的组合物
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
IN2012DN00781A (es) 2009-08-12 2015-06-26 Sigmoid Pharma Ltd
EP2593141B1 (en) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
ES2858517T3 (es) * 2014-11-07 2021-09-30 Sublimity Therapeutics Ltd Composiciones que comprenden ciclosporina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
ES2123477T1 (es) 1999-01-16
ES2123477T3 (es) 2002-08-01
AU6374596A (en) 1997-02-05
ATE213951T1 (de) 2002-03-15
DE69619700D1 (de) 2002-04-11
JPH11508592A (ja) 1999-07-27
DE873133T1 (de) 1999-05-06
CA2226219A1 (en) 1997-01-23
SE9502472L (sv) 1997-01-07
SE9502472D0 (sv) 1995-07-06
EP0873133A1 (en) 1998-10-28
BR9609332A (pt) 1999-05-25
NO980032D0 (no) 1998-01-05
EP0873133B1 (en) 2002-03-06
CZ1998A3 (cs) 1998-06-17
DE69619700T2 (de) 2002-10-24
WO1997002042A1 (en) 1997-01-23
NO980032L (no) 1998-03-03

Similar Documents

Publication Publication Date Title
SE504582C2 (sv) Cyklosporinkomposition baserad på en L2-fas
Constantinides Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects
EP0696920B1 (en) Improved pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug
EP0711550B1 (en) Cyclosporin-containing soft capsule compositions
FI109454B (fi) Menetelmä farmaseuttisen koostumuksen valmistamiseksi
US5206219A (en) Oral compositions of proteinaceous medicaments
US7799340B2 (en) Pharmaceutical compositions for lipophilic drugs
KR100377058B1 (ko) 경구용제약제조물
CA2106827C (en) Pharmaceutical compositions containing cyclosporins
AU2011206629B2 (en) Pharmaceutical compositions for oral administration of insulin peptides
JP2005516959A (ja) マイクロエマルション予備濃縮物
CA2471241A1 (en) Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant
AU719251B2 (en) Cyclosporin-containing soft capsule preparations
US6159933A (en) Emulsion preconcentrate comprising a cyclosporin, propylene carbonate, and glycerides
JP3748573B2 (ja) 医薬用組成物
US20010027178A1 (en) Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
AU753018B2 (en) Cyclosporin-containing soft capsule preparations
WO2004073693A1 (en) Soft capsule containing cyclosporine and it's manufacturing process
AU722285B2 (en) Cyclosporin-containing soft capsule preparations
KR19990047897A (ko) 사이클로스포린 함유 약학적 조성물
MXPA98003393A (es) Emulsion preconcentrada que comprende una ciclosporina y monoglicerido acetilado

Legal Events

Date Code Title Description
NUG Patent has lapsed